Shares of BP p.l.c. (LON:BP – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eleven ratings firms that are presently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 1 year price target among brokerages that have covered the stock in the last year is GBX 635.
Several equities analysts have recently issued reports on BP shares. Berenberg Bank reaffirmed a “buy” rating and set a GBX 700 price target on shares of BP in a research note on Wednesday, April 29th. UBS Group reaffirmed a “buy” rating on shares of BP in a research note on Tuesday, June 16th. Jefferies Financial Group reaffirmed a “neutral” rating and set a $6.50 price target on shares of BP in a research note on Thursday, May 21st. BNP Paribas Exane raised shares of BP from a “neutral” rating to an “outperform” rating in a research note on Friday, April 17th. Finally, Morgan Stanley raised shares of BP to an “overweight” rating in a research note on Wednesday, March 25th.
Check Out Our Latest Stock Analysis on BP
BP Price Performance
BP Company Profile
BP p.l.c. provides carbon products and services. The company operates through Gas & Low Carbon Energy, Oil Production & Operations, and Customers & Products segments. It engages in the production of natural gas, and integrated gas and power; trading of gas; operation of onshore and offshore wind power, as well as hydrogen and carbon capture and storage facilities; trading and marketing of renewable and non-renewable power; and production of crude oil. In addition, the company involved in convenience and retail fuel, EV charging, Castrol lubricant, aviation, B2B, and midstream businesses; refining and oil trading; and bioenergy business.
Recommended Stories
- Five stocks we like better than BP
- 3 Retail Winners Using Cash Flow to Stay Ahead
- 3 Tech ETFs That Could Bounce Back After the AI Selloff
- 3 Penny Stocks Under $5 Backed by Real Revenue Growth
- 3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
Receive News & Ratings for BP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BP and related companies with MarketBeat.com's FREE daily email newsletter.
